Multiple lines of evidence are converging on the idea that viruses you picked up decades ago might quietly be driving age-related diseases.
We've known for a few years that EBV raises MS risk 32-fold, and that molecular mimicry between an EBV protein and nerve insulation likely triggers brain autoimmunity. What remained unclear was why some people persistently carry EBV and others don't.
A new paper in from the (whose lab has been supported by ) and labs answers that at population scale. They mined ~735,000 human genomes for traces of Epstein-Barr virus, using reads of viral genomes that existing pipelines were throwing out as junk, and found that ~10% of people carry detectable EBV DNA in blood.
Carrying persistent EBV is associated with variable antigen processing, and the broader genetic architecture of viral persistence shares a component with lupus, rheumatoid arthritis, and type 1 diabetes.
Meanwhile, a separate line of very recent evidence is also pointing in that direction. The shingles vaccine, targeting another persistent herpesvirus, is showing ~20% dementia risk reduction in quasi-randomized studies which has been replicated across multiple countries.
There seems to be more at the intersection of immunity and age-related disease than we initially thought.
Conversation
Read the Nature paper here: nature.com/articles/s4158
The EBV papers mentioned:
- science.org/doi/10.1126/sc
- nature.com/articles/s4158
The shingles + dementia papers mentioned:
- cell.com/cell/fulltext/
-
Infectious disease and aging research tend to be funded separately, which means work like this often falls between categories. This is part of why the next round of includes a focused call on infectious disease and aging.
Details:
If you want to keep learning about aging and how we'll make progress in fighting it, check out our substack: norngroup.substack.com
Quote
Norn Group
@NornGroup
Infectious disease and aging research tend to be funded separately, which means work like this often falls between categories.
This is part of why the next round of @impetusgrants includes a focused call on infectious disease and aging.
Contact us to support it. Link below x.com/norngroup/stat…
There’s data to support that CMV (similar to EBV) accelerates aging.
Wouldn’t be surprised if EBV does as well.
Fascinating work. The 32-fold MS risk from EBV + 10% population carrier rate + 20% dementia reduction from shingles vaccine = a clear pattern. Key implications: 1) Viral persistence screening could stratify aging risk 2) Herpesvirus vaccines may have broader neuroprotective
so does this imply or direct that people should take antivirals regularly, or yearly? If so, which ones would perhaps make the most sense?
Some context on the herpesvirus part: the decrease in dementia risk with the specific shingles vaccine (and also seen in a RSV vaccine) appears due to the adjuvant used
I have been supporting this hypothesis for a long time now and one reason why I am so paranoid of the viral infections my kids wne thorough. Thanks for sharing!
saw your post this morning about PhIP-Seq being on your mind, this seems relevant
Infections overactivate the integrated stress response causing a loss of protein production quality control
Dormant viruses, especially rna viruses, reawakening are especially bad for it
Causes dementias. Especially when hit in the head. Micro bleeds awakening dormant virus.
the EBV-MS link already changed how I think about viral exposure. if this holds broadly it means a lot of what we call aging is actually manageable chronic infection.
Viruses you caught in your 20s might be your 80s’ problem child.